{
    "organizations": [],
    "uuid": "73272e142c7d4e9e172394b709bfcfcc2a459d32",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-molecular-partners-mp0250-clinical/brief-molecular-partners-mp0250-clinical-data-and-partner-interest-underline-progress-of-proprietary-oncology-compounds-idUSFWN1S21IW",
    "ord_in_thread": 0,
    "title": "Molecular Partners: Mp0250 Clinical Data And Partner Interest Underline Progress Of Proprietary Oncology Compounds",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 26 (Reuters) - MOLECULAR PARTNERS AG:\n* MOLECULAR PARTNERS -FURTHER MP0250 CLINICAL DATA AND PARTNER INTEREST UNDERLINE COâ€™ PROGRESS OF ITS PROPRIETARY ONCOLOGY COMPOUNDS Source text for Eikon: (Gdynia Newsroom)\n ",
    "published": "2018-04-26T13:15:00.000+03:00",
    "crawled": "2018-04-27T16:59:57.021+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "molecular",
        "partner",
        "ag",
        "molecular",
        "partner",
        "mp0250",
        "clinical",
        "data",
        "partner",
        "interest",
        "underline",
        "co",
        "progress",
        "proprietary",
        "oncology",
        "compound",
        "source",
        "text",
        "eikon",
        "gdynia",
        "newsroom"
    ]
}